Minireview: Mutations and Diseases of G Protein Coupled Receptors

References

• Birnhaumer M., Gilbert S., Rosenthal W. An extracellular CNDI mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand and coupling to the Gs/adenylyl Cyclase System. Mol. Pharmacol. 1994, in press
   Google Scholar
• Chung P. Z., Wang C. D., Potter P. C., Venter J. C., Fraser C. M. Site-directed mutagenesis and continuous expression of human β-adrenergic receptor. Identification of a conserved aspartate residue involved in agonist binding and receptor activation. J. Biol. Chem. 1988; 163: 4052–4055
   Google Scholar
• Clark A. J.L., McLoughlin L., Grossman A. Familial glucocorticoid deficiency associated with a point mutation in the adrenocorticotropin receptor. Lancet 1993; 341: 461–462
   PubMed Web of Science ®Google Scholar
• Cotecchia S., Exum S., Caron M. G., Letkowitz R. J. Regions of the α1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl. Acad. Sci. USA 1990; 87: 2896–2900
   PubMed Web of Science ®Google Scholar
• Dryja T. P., Berson E. L., Rao V. R., Oprian D. D. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nature Genet. 1993; 4: 280–283
   PubMed Web of Science ®Google Scholar
• Franke R. R., Koenig B., Sakmar T. P., Khorana H. G., Hofmann K. P. Rhodopsin mutants that bind but fail to activate transducin. Science 1990; 250: 123–125
   PubMedGoogle Scholar
• Franke R. R., Sakmar T. P., Graham R. M., Khorana H. G. Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin. J. Biol. Chem. 1992; 267: 14767–14774
   Google Scholar
• Fraser C. M., Chung F. Z., Wang C. D., Venter J. C. Site directed mutagenesis of human β-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high affinity agonist binding that is uncoupled from adenylate cyclase. Proc. Natl. Acad. Sci. USA 1988; 85: 5478–5482
   Google Scholar
• Horstman D., Brandon S., Wilson A. L., Guyer C. A., Cragoe E. J., Jr., Limbird L. E. An aspartate conserved among G-protein receptors confers allosteric regulation of α2-adrenergic receptors by sodium. J. Biol. Chem. 1990; 265: 21590–21595
   PubMed Web of Science ®Google Scholar
• Ji I., Ji T. H. Asp383 in the second transmembrane domain of the lutropin receptor is important for high affinity hormone binding and cAMP production. J. Biol. Chem. 1991; 266: 14953–14957
   Google Scholar
• Kjelsberg M. A., Cotecchia S., Ostrowski J., Caron M. G., Lefkowitz R. J. Constitutive activation of the α1b-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem. 1992; 267: 1430–1433
   PubMed Web of Science ®Google Scholar
• Kosugi S., Okajima F., Ban T., Hidaka A., Shenker A., Kohn L. D. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. J. Biol. Chem. 1992; 267: 24153–24156
   PubMed Web of Science ®Google Scholar
• Kremer H., Mariman E., Otten B. J., Moll G. W., Jr., Stoelinga G. B.A., Wit J. M., Jansen M., Drop S. L., Faas B., Ropers H-H., Brunner H. G. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum. Mol. Genet. 1993; 2: 1779–1783
   Google Scholar
• Lin S_L., Lin C. R., Gukovsky I., Lusis A. J., Sawchenko P. E., Rosenfeld M. G. Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 1993; 364: 208–213
   PubMed Web of Science ®Google Scholar
• Nash M. I., Hollyfield J. G., Al-Ubaidi M. R., Baehr W. Simulation of autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc. Natl. Acad. Sci. USA 1993; 90: 5499–5503
   Google Scholar
• Neve K. A., Cox B. A., Henningsen R. A., Spanoyannis A., Neve R. L. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol. Pharmacol. 1991; 39: 733–739
   Google Scholar
• Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J., Vassart G. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993; 365: 649–651
   PubMed Web of Science ®Google Scholar
• Pollak M. R., Brown E. M., Chou Y-H.W., Marx S. J., Steinmann B., Levi T., Seidman C. E, Seidman J. D. Mutations in the human Ca2+ sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 1297–1303
   PubMed Web of Science ®Google Scholar
• Quintana J., Wang H., Ascoli M. The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G-protein coupled receptors. Mol. Endo. 1993; 7: 767–775
   Google Scholar
• Rao V. R., Cohen G. B., Oprian D. D. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 1994; 367: 639–642
   PubMed Web of Science ®Google Scholar
• Ren Q., Kurose H., Lefkowitz R. J., Cotecchia S. Constitutively active mutants of the α2-adrenergic receptor. J. Biol. Chem. 1993; 268: 16483–16487
   PubMed Web of Science ®Google Scholar
• Robbins L. S., Nadeau J. H., Johnson K. R., Kelly M. A., Roselli-Rehfuss L., Baack E., Mountjoy K. G., Cone R. D. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993; 72: 827–834
   PubMed Web of Science ®Google Scholar
• Robinson P. R., Cohen; G. B., Zhukovsky E. A., Oprian D. D. Constitutively active mutants of rhodopsin. Neuron 1992; 9: 719–725
   PubMed Web of Science ®Google Scholar
• Rosenthal W., Seibold A., Antaramian A., Lonergan M., Arthus M.-F., Hendy G. N, Birnbaumer M., Bichet D. G. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 1992; 359: 233–235
   PubMed Web of Science ®Google Scholar
• Rosenthal W., Antaramian A, Gilbert S., Birnbaumer M. Nephrogenic diabetes insipidus: a V2 vasopressin receptor unable to stimulate adenylyl cyclase. J. Biol. Chem. 1993; 268: 13030–13033
   PubMed Web of Science ®Google Scholar
• Samama P., Cotecchia S., Costa T., Lefkowitz R. J. A mutation-induced activated state of the β2-adrenergic receptor. J. Biol. Chem. 1993; 268: 4625–4636
   PubMed Web of Science ®Google Scholar
• Shenker A., Laue L., Kosugi S., Merendino J. J., Minegishi T., Cutler G. B., Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993; 365: 652–654
   PubMed Web of Science ®Google Scholar
• Stein S. A., Oats E. L., Hall C. R., Grumbbles R. M., Fernandez L. M., Taylor N. A., Puett D., Gin S. Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol. Endocrinol. 1994; 8: 129–138
   Google Scholar
• Strader C. D., Sigal I. S., Candelore M. R., Rands E., McGill W. S., Dixon R. A.F. Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 1988; 263: 10267–10271
   PubMed Web of Science ®Google Scholar
• Surprenant A., Horstman D., Akbarali H., Limbird L. E. A point mutation of cloned α-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 1992; 257: 977–980
   PubMedGoogle Scholar
• Tsigos C., Arai K., Hung W., Chrousos G. P. Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene. J. Clin. Invest. 1993; 92: 2458–2461
   PubMed Web of Science ®Google Scholar
• Henderson R., Unwin P. N.T. Three-dimensional model of purple membrane obtained by electron microscopy. Nature 1975; 257: 28–32
   PubMed Web of Science ®Google Scholar
• Henderson R., Baldwin J. M., Ceska T. A., Zemlin F., Beckmann E., Diowning K. H. Model for the structure of bacteriorhodopsin based in high-resolution electron cryo-microscopy. J. Mol. Biol. 1990; 213: 899–929
   PubMed Web of Science ®Google Scholar
• Schertler G. F.X., Villa C., Henderson R. Projection structure of rhodopsin. Nature 1993; 362: 770–772, 1993
   PubMed Web of Science ®Google Scholar
• Baldwin J. The Probable arrangement of the helices in G-protein coupled receptors. EMBO J. 1993; 12: 1693–1703
   PubMed Web of Science ®Google Scholar
• Dixon R. A.F., Sigal I. S., Strader C. D. Structure function analysis of the β-adrenergic receptor. Cold Spring Harbor. Symp. Quant. Biol. 1988; 53: 487–497
   PubMedGoogle Scholar
• Savarese T. M., Fraser C. M. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem. J. 1992; 283: 1–19
   PubMed Web of Science ®Google Scholar
• Vu T.-K. H., Hung D. T., Wheaton V. I., Coughlin S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057–1068
   PubMed Web of Science ®Google Scholar
• Ostrowski J., Kjelsberg M. A., Caron M. G., Lefkowitz R. J. Mutagenesis of the β2-adrenergic receptor. how structure elucidates function. Ann. Rev. Pharmacol. Toxicol. 1992; 32: 167–183
   PubMedGoogle Scholar
• Surprenant A., Horstman D., Akbarali H., Limbird L. E. A point mutation of cloned α-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 1992; 257: 977–980
   PubMedGoogle Scholar
• Pasternak G. W., Snyder S. H. Indentification of novel high affinity opiate receptor binding in rat brain. Nature 1975; 253: 563–565
   PubMed Web of Science ®Google Scholar
• Kanaho Y., Tsai S.-C., Adamik R., Hewlett E. L., Moss J., Vaughan M. Rhodopsin-enhanced GTPase activity of the inhibitory GTP-binding protein of adenylate cyclase. J. Biol. Chem. 1984; 259: 7378–7381
   PubMed Web of Science ®Google Scholar
• Florio V. A., Sternweis P. C. Reconstitution of resolved muscarinic cholinergic receptors with purified GTP-binding proteins. J. Biol. Chem. 1985; 260: 3477–3483
   PubMed Web of Science ®Google Scholar
• Florio V. A., Sternweis P. C. Mechanism of muscarinic receptor action on G0 in reconstituted phospholipid vesicles. J. Biol. Chem. 1989; 264: 3909–3915
   Google Scholar
• Phillips W. J., Cerione R. A. Rhodopsin/transducin interactions. I. Characterization of the binding of the transducin-βγ subunit complex to rhodopsin using fluorescence spectroscopy. J. Biol. Chem. 1992; 267: 17032–17039
   Google Scholar
• Phillips W. J., Wong S. C., Cerione R. A. Rhodopsin/transducin interactions. II. Influence of the transducin-βγ subunit complex on the coupling of the transducin-α subunit to rhodopsin. J. Biol. Chem. 1992; 267: 17040–17046
   Google Scholar
• Wess J., Bonner T. I., Derje F., Brann M. R. Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers. Mol. Pharmacol. 1990; 38: 517–523
   Google Scholar
• Cheung A. H., Sigal I. S., Dixon R. A.F., Strader C. D. Agonistpromoted sequestration iof the β2-adrenergic receptor requires regions involved in functional couling with Gs. Mol. Pharmacol. 1989; 34: 132–138
   Google Scholar
• Cheung A. H., Huang R-R. C., Graziano M. P., Strader C. D. Specific activation of Gs by synthetic peptides corresponding to an intracellular loop of the β-adrenergic receptor. FEBS Lett. 1991; 279: 277–280
   Google Scholar
• Okamoto T., Murayama Y., Hayashi Y., Inagaki M., Ogata E., Nishimoto I. Identification of a Gs activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell 1991; 67: 723–730
   Google Scholar
• Nishimoto I. The IGF-II receptor system. a G protein-linked mechanism. Molecular Reproduction and Development 1993; 35: 398–407
   Google Scholar
• Cotecchia S., Exum S., Caron M. G., Lefkowitz R. J. Regions of the α1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function Proc. Natl. Acad. Sci. USA 1990; 87: 2896–2900
   PubMed Web of Science ®Google Scholar
• Kjelsberg M. A., Cotecchia S., Ostrowski J., Caron M. G., Lefkowitz R. J. Constitutive activation of the α1B-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem. 1992; 267: 1430–1433
   PubMed Web of Science ®Google Scholar
• Samama P., Cotecchia S., Costa T., Lefkowitz R. J. A mutation induced activated state of the β2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 1993; 268: 4625–4636
   Google Scholar
• Ren Q., Kurose H., Lefkowitz R. J., Cotecchia S. Constitutively active mutants of the α2-adrenergic receptor. J. Biol. Chem. 1993; 268: 16483–16487
   PubMed Web of Science ®Google Scholar
• Nash M. I., Hollyfield J. G., Al-Ubaidi M. R., Baehr W. Simulation of autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc. Natl. Acad. Sci. USA 1993; 90: 5499–5503
   Google Scholar
• Robinson P. R., Cohen G. B., Zhukovsky E. A., Oprian D. D. Constitutively active mutants of rhodopsin. Neuron 1992; 9: 719–725
   PubMed Web of Science ®Google Scholar
• Birnbaumer M., Seibold A., Gilbert S., Ishido M., Barberis C., Antaramian A., Brabet P., Rosenthal W. Molecular cloning of the human antidiuretic hormone receptor. Nature 1992; 357: 333–335
   PubMed Web of Science ®Google Scholar
• Seibold A., Brabet P., Rosenthal W., Birnbaumer M. Structural and chromosomal localization of the human antidiuretic receptor gene. Am. J. Hum. Genet. 1992; 51: 1078–1083
   PubMed Web of Science ®Google Scholar
• Rosenthal W., Seibold A., Antaramian A., Lonergan M., Arthus M.-F., Hendy G. N., Birnbaumer M., Bichet D. G. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 1992; 359: 233–235
   PubMed Web of Science ®Google Scholar
• Rosenthal W., Antaramian A., Gilbert S., Birnbaumer M. Nephrogenic diabetes insipidus: a V2 vasopressin receptor unable to stimulate adenylyl cyclase. J. Biol. Chem. 1993; 268: 13030–13033
   PubMed Web of Science ®Google Scholar
• Birnbaumer M., Gilbert S., Rosenthal W. An extracellular NDI mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand and coupling to the Gs/adenylyl cyclase system. Mol. Endocrinol. 1994, in press
   Google Scholar
• Robbins L. S., Nadeau J. H., Johnson KR., Kelly M. A., Roselli-Rehfuss L., Baack E., Mountjoy KG., Cone R. D. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993; 72: 827–834
   PubMed Web of Science ®Google Scholar
• Jackson I. J. More colour than meets the eye. Current Biology 1993; 3: 510–521
   Google Scholar
• Shenker A., Laue L., Kosugi S., Merendino J. J., Minegishi T., Cutler G. B., Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 1993; 365: 652–654
   Google Scholar
• Kremer H., Mariman E., Otten B. J., Moll G. W., Jr., Stoelinga G. B.A., Wit J. M., Jansen M., Drop S. L., Faas B., Ropers H-H., Brunner H. G. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum. Mol. Genet. 1993; 2: 1779–1783
   PubMed Web of Science ®Google Scholar
• Ji I., Ji T. H. Asp383 in the second transmembrane domain of the lutropin receptor is important for high affinity hormone binding and cAMP production. J. Biol. Chem. 1991; 266: 14953–14957
   Google Scholar
• Kobilka B. K., Kobilka T. S., Daniel K., Regan J. W., Caron M. G., Lefkowitz R. J. Chimeric α2/β2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 1988; 240: 130–1316
   Google Scholar
• Rubenstein R. C., Wong S. K.P., Ross E. M. The hydrophobic tryptic core of the β-adrenergic receptor retains GS regulatory activity in response to agonists and thiols. J. Biol. Chem. 1987; 262: 16655–16662
   Google Scholar
• Suryanarayana S., von Zastrow M., Kobilka B. K. Identification of intramolecular interactions in adrenergic receptors. J. Biol. Chem. 1992; 267: 21991–21994
   PubMed Web of Science ®Google Scholar
• Tsai-Morris C. H., Buczko E., Wang W., Dufau M. L. Intronic nature of the rat luteinizing hormone receptor gene defines a soluble receptor subspecies with hormone binding activity. J. Biol. Chem. 1990; 265: 19385–19388
   Google Scholar
• Osenberg D., Marsters S. A., O'Dowd B. F., Jin H., Havlik S., Peroutka S. J., Ashkenazi A. A single amino acid difference confers major pharmacological variation between human and rodent 5HT-1B receptors. Nature 1992; 360: 161–163
   Google Scholar
• Gether U., Johansen T. E., Snider M. R., Lowe J. A., Nakanishi S., Schwartz T. W. Different binding epitopes in the NK1 receptor for substance P and a non-peptide antagonist. Nature 1993; 362: 345–348
   PubMed Web of Science ®Google Scholar
• Wess J., Bonner T. I., Derje F., Brann M. R. Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers. Mol. Pharmacol. 1990; 38: 517–523
   Google Scholar
• Blüml K., Mutschler E., Wess J. Identification of an intracellular tyrosine residue critical for muscarinic receptor-mediated stimulation of phosphatidylinositol hydrolysis. J. Biol. Chem. 1994; 269: 402–405
   Google Scholar
• Benovic J. L., Kühn H., Weyand I., Codina J., Caron M. G., Lefkowitz R. J. Functional desensitization of the isolated β-adrenergic receptor by the β-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48k protein). Proc. Natl. Acad. Sci. USA 1987; 84: 8879–8882
   PubMedGoogle Scholar
• Benovic J. L., De Blasi A., Stone W. C., Caron M. G., Lefkowitz R. J. β-Adrenergic receptor kinase: primary structure delineates a multigene family. Science 1989; 246: 235–240
   PubMed Web of Science ®Google Scholar
• Lohse M. J., Andexinger S., Pitcher J., Trukawinski S., Codina J., Faure J.-P., Caron M. G., Lefkowitz R. J. Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of β-arrestin and arrestin in the β2-adrenergic receptor and rhodopsin systems. J. Biol. Chem. 1992; 267: 8558–8564
   PubMed Web of Science ®Google Scholar
• Haga K., Haga T. Activation by G protein βγ subunits of agonist- or light-dependent phosphorylation of muscarinic acetylcholine receptors and rhodopsin. J. Biol. Chem. 1992; 267: 2222–2227
   PubMedGoogle Scholar
• Kameyama K., Haga K., Haga T., Kontani K., Katada T., Fukada Y. Activation by G protein βγ subunits of β-adrenergic and muscarinic receptor kinase. J. Biol. Chem. 1993; 268: 7753–7758
   Google Scholar
• Pitcher J. A., Inglese J., Higgins J. B., Arriza J. L., Casey P. J., Kim C., Benovic J. L., Kwatra M. M., Caron M. G., Lefkowitz R. J. Role of βγ subunits of G proteins in targeting of the β-adrenergic receptor kinase to membrane-bound receptors. Science 1992; 257: 1264–1267
   PubMed Web of Science ®Google Scholar
• Inglese J., Freedman N. J., Koch W. J., Lefkowitz R. J. Structure and mechanism of the G protein coupled receptor kinases. J. Biol. Chem. 1993; 268: 23735–23738
   PubMed Web of Science ®Google Scholar
• Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J., Vassart G. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993; 365: 649–651
   PubMed Web of Science ®Google Scholar
• Dalman H. M., Neubig R. R. Two peptides from the α2A-adrenergic receptor alter G protein coupling by distinct mechanisms. J. Biol. Chem. 1991; 266: 11025–11029
   Google Scholar
• Ikezu T., Okamoto T., Ogata E., Nishimoto I. Amino acids 356-372 constitute a Gi-activator sequence of the α2-adrenergic receptor and have a Phe substitute in the G protein-activator sequence motif. FEBS Lett. 1992; 311: 29–32
   PubMed Web of Science ®Google Scholar
• Rodbell M., Krans H. M.J., Pohl S. L., Birnbaumer L. The glucagonsensitive adenyl cyclase system in plasma membranes of rat liver. IV. Binding of glucagon: effect of guanyl nucleotides. J. Biol. Chem. 1971; 246: 1872–1876
   Google Scholar
• Maguire M. E., Van Arsdale P. M., Gilman A. G. An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor. Mol. Pharmacol. 1976; 12: 335–339
   PubMed Web of Science ®Google Scholar
• Lefkowitz R. J., Mullikan D., Caron M. G. Regulation of β-adrenergic receptors by guanyl-5′-yl imidodiphosphate and other purine nucleotides. J. Biol. Chem. 1976; 251: 4686–4692
   PubMed Web of Science ®Google Scholar
• Berrie C. P., Birdsall N. J.M., Burgen A. S.V., Hulme E. C. Guanine nucleotides modulate muscarinic receptor binding in the heart. Biochem. Biophys. Res. Comm. 1979; 87: 1000–1005
   PubMed Web of Science ®Google Scholar
• Rosenberger L. B., Roeske W. R., Yamamura H. I. The regulation of muscarinic cholinergic receptors by guanine nucleotides in cardiac tissue. Europ. J. Pharmacol. 1979; 56: 179–180
   Google Scholar
• Grandt R, Aktories K., Jakobs K. H. Guanine nucleotides and monovalent cations increase agonist affinity of prostaglandin E2 receptors in hamster platelets. Mol. Pharmacol. 1982; 22: 320–326
   Google Scholar
• Sugimoto Y., Negishi M., Hayashi Y., Namba T., Honda A., Watabe A., Hirata M., Narumiya S., Ichikawa A. Two isoforms of EP3 receptor with different carboxylterminal domains. Identical ligand binding properties and different coupling properties with Gi proteins. J. Biol. Chem. 1993; 268: 2712–2718
   PubMedGoogle Scholar
• Karnik S. S., Sakmar T. P, Chen H. B., Khorana H. G. Cysteine residues 110 and 187 are essential for the formation of correct structureof bovine rhodopsin. Proc. Natl. Acad. Sci. USA 1988; 85: 8459–8463
   PubMed Web of Science ®Google Scholar
• O'Dowd B. F., Hnatowitch M., Caron M. G., Lefkowitz R. J., Bouvier M. Palmitoylation of the human beta 2-adrenergic receptor: mutation of Cys-341 in the carboxyl tail leads to an uncoupled non-palmitoylated form of the receptor. J. Biol. Chem. 1989; 264: 7564–7569
   PubMedGoogle Scholar
• Moffett S. W., Mouillac B., Bonin H., Bouvier M. Altered phosphorylation and desensitization patterns of a human β2-adrenergic receptor lacking the palmitoylated Cys341. EMBO J. 1993; 12: 349–356
   PubMedGoogle Scholar
• Kennedy M. E., Limbird L. E. Mutations of the α2A-adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G protein coupling. J. Biol. Chem. 1993; 268: 8003–8011
   PubMed Web of Science ®Google Scholar
• Chabre M. Triger. Amplification mechanisms in visual phototransduction. Ann. Rev. Biophys. Biophys. Chem. 1985; 14: 331–347
   PubMedGoogle Scholar
• Stryer L. Molecular basis for visual excitation. Cold Spring Harbor. Symp. Quant. Biol. 1988; 53: 283–294
   Google Scholar
• Braiman M., Bubis J., Doi T., Chen H.-B., Flitsch S. L., Franke R. R., Giles-Gonzalez M. A., Graham R. M., Karnik S. S., Khorana G. G., Knox B. E., Kebs M. P., Marti T., Mogi T., Nakayama T., Oprian D. D., Puckett K. L., Sakmar T. P., Stern L. J., Subramanian S., Thompson D. A. Studies on light transduction by bacteriorhodopsin and rhodopsin. Cold Spring Harbor. Symp. Quant. Biol. 1988; 53: 355–364
   Google Scholar
• Zhukovsky E. A., Robinson P. R., Oprian D. D. Transducin activation by rhodopsin without a covalent bond to the 11-cis-retinal chromophore. Science 1991; 251: 558–559
   PubMed Web of Science ®Google Scholar
• Bichet D. G., Arthus M.-F., Lonergan M., Hendy G. N., Paradis A. J., Fujiwara T. M., Morgan K., Gregory M. C., Rosenthal W., Antaramian A., Birnbaumer M. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J. Clin. Invest. 1993; 92: 1262–1268
   Google Scholar
• Holtzman E. J., Harris H. W.H., Kolakowski L. F., Guay-Woodford L. M., Botelho B., Aussiello D. A. A molecular defect in vasopressin V2-receptor gene causing nephrogenic diabetes insipidus. N. Engl. J. Med. 1993; 328: 1534–1537
   Google Scholar
• Knoers N. V.A.M., Verdijk M., Monnens L. A.H., van den Ouweland A. M. W., van Oost B. A. Inheritance of mutations in the vasopressin V2 receptor gene in 15 Dutch families with congenital nephrogenic diabetes insipidus. Vasopressin, P. Gross, D. Richter, G. L. Robertson, J. Libbey, BerlinGermany 1993; 571–572, Eurotext, Proceedings of the W International Vasopressin Conference May 1993
   Google Scholar
• Merendino J. J., Spiegel A. M., Crawford J. D., O'Carroll A-M., Brownstein M. J., Lolait S. J. A mutation in the vasopressin V2 receptor gene in a kindred with X-linked nephrogenic diabetes insipidus. N. Engl. J. Med. 1993; 328: 1538–1541
   Google Scholar
• Pan Y., Metzenberg A., Das S., Gitschier J. Mutations in the V2 vasopressin receptor gene are associated with x-linked nephrogenic diabetes insipidus. Nature Genetics 1992; 2: 103–106
   PubMed Web of Science ®Google Scholar
• van den Ouweland A. M. W., Dreesen J. C.F.M., Verdijk M., Knoers N. V.A.M., Monnens L. A.H., Rocchi M., van Oost B. A. Mutations in the vasopressin type 2 receptor gene AVPR2 associated with nephrogenic diabetes insipidus. Nature Genetics 1992; 2: 99–102
   Google Scholar